1. AMD-Associated HTRA1 Variants Do Not Influence TGF-β Signaling in Microglia
- Author
-
Isha, Akhtar-Schaefer, Raphael, Reuten, Manuel, Koch, Markus, Pietsch, and Thomas, Langmann
- Subjects
Macular Degeneration ,Genotype ,Transforming Growth Factor beta ,Serine Endopeptidases ,Humans ,Genetic Predisposition to Disease ,High-Temperature Requirement A Serine Peptidase 1 ,Microglia ,Polymorphism, Single Nucleotide ,Signal Transduction - Abstract
Genetic variants of high-temperature requirement A serine peptidase 1 (HTRA1) and age-related maculopathy susceptibility 2 (ARMS2) are associated with age-related macular degeneration (AMD). One HTRA1 single nucleotide polymorphism (SNP) is situated in the promotor region (rs11200638) resulting in increased expression, while two synonymous SNPs are located in exon 1 (rs1049331:C T, rs2293870:G T). HtrA1 is known to inhibit transforming growth factor-β (TGF-β) signaling, a pathway regulating quiescence of microglia, the resident immune cells of the brain and retina. Microglia-mediated immune responses contribute to AMD pathogenesis. It is currently unclear whether AMD-associated HTRA1 variants influence TGF-β signaling and microglia phenotypes. Here, we show that an HtrA1 isoform carrying AMD-associated SNPs in exon 1 exhibits increased proteolytic activity. However, when incubating TGF-β-treated reactive microglia with HtrA1 protein variants, neither the wildtype nor the SNP-associated isoforms changed microglia activation in vitro.
- Published
- 2019